Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap289.61M
Enterprise Value321.34M
Trailing P/E63.68
Forward P/E73.05
ZJYL
(NASDAQ)Jin Medical International Ltd.
$1.85-- (--)
Loading... - Market loading
Jin Medical International (ZJYL) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)7.01
Forward Price/Sales6.19
Price/Book (mrq)10.46
Price/Tangible Book (mrq)10.86
Price/OCF (ttm)182.73
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue7.27
EV/Earnings66.02
EV/EBITDA67.63
EV/EBIT528.36
EV/FCF-63.27
Stock Price
Current price, 52-week range, and moving averages
Current Price$1.85
1-Day Change-1.98%
52-Week High$5.40
52-Week Low$0.22
52-Week Change166.56%
YTD Change-56.02%
1-Year Change204.47%
50-Day MA$2.63
200-Day MA$1.49
Avg Volume (30 day)27.91K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding156.55M
Book Value per Share$0.19
Net Cash per Share$-0.07
FCF per Share$-0.03
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin35.72%
EBITDA Margin (ttm)10.75%
EBIT Margin (ttm)1.38%
Operating Margin (ttm)9.61%
Pretax Margin (ttm)13.08%
Profit Margin (ttm)11.01%
FCF Margin (ttm)-11.49%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)16.42%
Return on Assets (ttm)9.12%
Return on Invested Capital (ttm)1.25%
Return on Capital Employed (ttm)2.06%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue44.19M
Gross Profit15.78M
Operating Income4.25M
Pretax Income5.78M
Net Income4.87M
EBITDA4.75M
EBIT608.18K
Diluted EPS$0.03
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow1.70M
Capital Expenditures6.77M
Free Cash Flow-5.08M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth88.02%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)53.37M
Cash & Securities (mrq)7.46M
Net Cash (mrq)-11.38M
Net Cash per Share$-0.07
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)18.84M
Working Capital (mrq)20.35M
Total Equity (mrq)29.64M
Book Value per Share$0.19
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.86
Quick Ratio (mrq)1.65
Debt/Equity (mrq)0.64
Debt/EBITDA (ttm)3.96
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield1.57%
FCF Yield-1.64%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score9.69
Piotroski F-Score5/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$0.36
Graham Upside/Downside-81.62%
Frequently Asked Questions About Jin Medical International Statistics
What are the key financial metrics for ZJYL?
Jin Medical International Ltd. (ZJYL) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is ZJYL's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Jin Medical International is overvalued or undervalued.
How do I read ZJYL's profitability ratios?
Jin Medical International's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do ZJYL's debt ratios indicate?
The financial health section shows Jin Medical International's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is ZJYL's dividend analysis?
The dividend section covers Jin Medical International's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.